News

The completion of current good manufacturing practices (cGMP) manufacture of RiVax forms one of the crucial milestones in the development of the vaccine, which is being conducted under

This study is part of a major drug development program to evaluate the prevention and treatment of dyslipidemia, atherosclerosis, and coronary heart disease. Pacific will provide the sponsor

BioMap profiling can provide in-depth characterization of drug function, including defining mechanism of action and secondary activities, and can provide insights into potential clinical applications. BioMap systems are

The study will be conducted in the US and Canada and involves about 50 clinical centers. More than 2,000 patients will be included in the study and 1,270

Investigators will assess the efficacy, as well as the safety and tolerability, of ALS-08 in separate combinations with celecoxib (marketed as Celebrex by Pfizer) and minocycline in patients

MedImmune will apply the technology to its intranasal FluMist product and its next-generation, refrigerator-stable formulation, CAIV-T. Creation of new vaccine strains is the first step in the influenza

The drug combines the ophthalmic steroid prednisolone acetate with the antibiotic solution prednisolone. Both compounds are commonly prescribed by ophthalmologists, according to Ista Pharmaceuticals, a specialty pharmaceutical company

Abbott and AstraZeneca recently announced that they have formed a collaboration to develop a single pill for lipid management that will combine the active ingredient of Abbott’s fibrate

According to the companies, the research could extend drug discovery efforts into disease targets where traditional discovery technologies have not been successful. During the collaboration, the companies will